Literature DB >> 19137654

Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals.

Erica M C D'Agata1, Glenn F Webb, Mary Ann Horn, Robert C Moellering, Shigui Ruan.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) has traditionally been associated with infections in hospitals. Recently, a new strain of MRSA has emerged and rapidly spread in the community, causing serious infections among young, healthy individuals. Preliminary reports imply that a particular clone (USA300) of a community-acquired MRSA (CA-MRSA) strain is infiltrating hospitals and replacing the traditional hospital-acquired MRSA strains. If true, this event would have serious consequences, because CA-MRSA infections in hospitals would occur among a more debilitated, older patient population.
METHODS: A deterministic mathematical model was developed to characterize the factors contributing to the replacement of hospital-acquired MRSA with CA-MRSA and to quantify the effectiveness of interventions aimed at limiting the spread of CA-MRSA in health care settings.
RESULTS: The model strongly suggests that CA-MRSA will become the dominant MRSA strain in hospitals and health care facilities. This reversal of dominant strain will occur as a result of the documented expanding community reservoir and increasing influx into the hospital of individuals who harbor CA-MRSA. Competitive exclusion of hospital-acquired MRSA by CA-MRSA will occur, with increased severity of CA-MRSA infections resulting in longer hospitalizations and a larger in-hospital reservoir of CA-MRSA.
CONCLUSIONS: Improving compliance with hand hygiene and screening for and decolonization of CA-MRSA carriers are effective strategies. However, hand hygiene has the greatest return of benefits and, if compliance is optimized, other strategies may have minimal added benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19137654      PMCID: PMC2666259          DOI: 10.1086/595844

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration.

Authors:  Erika M C D'Agata; Pierre Magal; Damien Olivier; Shigui Ruan; Glenn F Webb
Journal:  J Theor Biol       Date:  2007-08-25       Impact factor: 2.691

Review 3.  Modelling an outbreak of an emerging pathogen.

Authors:  Emily Kajita; Justin T Okano; Erin N Bodine; Scott P Layne; Sally Blower
Journal:  Nat Rev Microbiol       Date:  2007-09       Impact factor: 60.633

4.  Mupirocin - Are we in danger of losing it?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-05

5.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

7.  Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.

Authors:  Heiman F L Wertheim; Jeroen Verveer; Hélène A M Boelens; Alex van Belkum; Henri A Verbrugh; Magreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

Review 9.  Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Loren G Miller; Binh An Diep
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

10.  Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Authors:  Anne Tristan; Michele Bes; Helene Meugnier; Gerard Lina; Bülent Bozdogan; Patrice Courvalin; Marie-Elisabeth Reverdy; Mark C Enright; François Vandenesch; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more
  81 in total

1.  NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs.

Authors:  James D Thacker; Brian J Balin; Denah M Appelt; Sihem Sassi-Gaha; Mitali Purohit; Richard F Rest; Carol M Artlett
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.

Authors:  Anna C Shore; Orla M Brennan; Ralf Ehricht; Stefan Monecke; Stefan Schwarz; Peter Slickers; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

Review 3.  Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

Authors:  Leticia I Llarrull; Jed F Fisher; Shahriar Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

4.  Senescence and antibiotic resistance in an age-structured population model.

Authors:  Patrick De Leenheer; Jack Dockery; Tomás Gedeon; Sergei S Pilyugin
Journal:  J Math Biol       Date:  2009-11-12       Impact factor: 2.259

5.  Community-associated MRSA - the forthcoming epidemic?

Authors:  Burkhard Springer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils.

Authors:  Mark J White; Jeffrey M Boyd; Alexander R Horswill; William M Nauseef
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

7.  The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion.

Authors:  Joanna Pressley; Erika M C D'Agata; Glenn F Webb
Journal:  J Theor Biol       Date:  2010-03-27       Impact factor: 2.691

Review 8.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

9.  Modeling the role of altruism of antibiotic-resistant bacteria.

Authors:  Wendi Wang; Xingfu Zou
Journal:  J Math Biol       Date:  2013-03-30       Impact factor: 2.259

10.  Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  N Farag; L Mahran; K Abou-Aisha; M El-Azizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.